Market Overview:
Viral vectors are used in gene therapies. Viral vectors are playing a vital role in the healthcare sector, as many research activities are underway to develop drugs to treat life-threatening conditions, such as cardiovascular diseases, cancer, hematology, ophthalmology, and many more. Viral vectors are tools commonly used by molecular biologists to deliver genetic material into cells. While, plasmids have been key to the development of molecular biotechnology. They act as delivery vehicles, to introduce foreign DNA into bacteria. Plasmids are important for bacterial evolution and adaptation to the changing environment, as they carry genes which carry beneficial traits for the bacterial cell. Viral vector and plasmid DNA are tools to transfer genetic material into cells.
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/3637
Key Market Drivers:
Increasing utilization of viral vectors and plasmid to develop various treatments and ongoing clinical trials on the viral vectors and plasmid DNA are expected to augment the growth of the viral vector and plasmid DNA testing services market during the forecast period. For instance, in July 2021, Zydus Cadila applied for Emergency Use Authorization (EUA) to the office of Drug Controller General of India (DCGI) for ZyCoV-D – its Plasmid DNA Vaccine against COVID-19. It is the world’s first Plasmid DNA vaccine for COVID-19.
Moreover, increasing prevalence of as cardiovascular diseases, cancer, hematologic diseases, and ophthalmic diseases worldwide is expected to accelerate the growth of the viral vector and plasmid DNA testing services market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking an estimated 17.9 million lives each year, and cancer is also one of the leading cause of death worldwide, accounting for nearly 10 million deaths in 2020.
COVID-19 Impact Analysis:
The pandemic has created lucrative opportunities for key players in the viral vector and plasmid DNA testing services market. For instance, pharma companies such as Janssen Pharmaceuticals and AstraZeneca, have developed viral vector-based COVID-19 vaccines. Moreover, several viral vector-based vaccines are currently in the development phase. In short, the pandemic has increased the demand for viral vector and plasmid DNA testing services. According to WHO, worldwide, as of 5:15pm CEST, 30 September 2021, there have been 233,136,147 confirmed cases of COVID-19, including 4,771,408 deaths, and as of 29 September 2021, a total of 6,143,369,655 vaccine doses have been administered worldwide. This in turn is expected to boost the growth of the market, worldwide.
Competitive Landscape:
Major players operating in the global viral vector and plasmid DNA testing services market are Genezen Laboratories, ViruSure GmbH, Takara Bio Inc., Advanced Bioscience Laboratories, Inc., FinVector Vision Therapies, Eurofins Scientific, Lonza, Merck KGaA, WuXi AppTec Co., Ltd., Charles River Laboratories, Inc., and Cobra Biologics and Pharmaceutical Services, among others.
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/3637
Key Takeaways:
The viral vector and plasmid DNA testing services market is expected to exhibit a CAGR of XX % during the forecast period owing to the increasing adoption of inorganic growth strategies, such as collaboration and acquisition, by key players. For instance, in May 2021, Charles River Laboratories International signed a definitive agreement to acquire Vigene Biosciences, Inc., to expand its cell and gene therapy portfolio to span each of the major CDMO platforms – cell therapy, viral vector, and plasmid DNA production.
Among regions, North America and Asia Pacific are expected to witness robust growth in the viral vector and plasmid DNA testing services market due to the increasing prevalence of cancer and cardiovascular diseases, increasing employment of viral vectors and plasmid DNA for the R&D of advanced therapies, and rising demand for viral vector-based vaccines for infectious diseases. For instance, in April 2021, the Drug Controller General of India (DCGI) approved the use of the Sputnik V (COVID-19 vaccine) for usage, according to the Russian Direct Investment Fund (RDIF). It is an adenovirus viral vector vaccine.
Buy This Complete A Business Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/insight/buy-now/3637
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Testing Services
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Guidelines
- Regulatory Scenario
- Merger & Acquisitions
- Product Launch
- Epidemiology
- Pipeline Analysis
- New Product Launches
- List of Approved Products
- Pest Analysis
- Market Dynamics
- Global Viral Vector and Plasmid DNA Testing Services Market, By Testing Services, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Safety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Genetic Characterization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Purity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Identity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Potency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Viral Vector and Plasmid DNA Testing Services Market, By End User, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Pharmaceutical and Biotechnological Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Viral Vector and Plasmid DNA Testing Services Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Testing Services, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Testing Services, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Testing Services, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Testing Services, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Pakistan
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Testing Services, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Testing Services, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Charles River Laboratories, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- WuXi AppTec Co., Ltd.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cobra Biologics and Pharmaceutical Services
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lonza
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eurofins Scientific
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- FinVector Vision Therapies
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Advanced Bioscience Laboratories, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ViruSure GmbH
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genezen Laboratories
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Charles River Laboratories, Inc.
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
Inquire more about this report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/3637
Our analysts are experts in this field with years of experience. We at Coherent Market Insights maintain the highest level of accuracy and transparency in the report. The primary and secondary resources used in the report are taken from reliable and high authority sources to deliver 100% accurate and trusted data.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
